Genelux Corporation operates with a lean, specialized workforce numbering approximately 26 employees. As a clinical-stage biopharmaceutical firm, its compact team primarily consists of expert scientists, clinical research coordinators, engineering personnel, and administrative leadership focused on executing complex multicenter trials and advancing its viral immunotherapy drug candidates without the overhead of massive commercial manufacturing staff.